Clinical Trial Update: A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers [Phase 2]

View source ↗

Summary

Phase 2a trial of FOL-005 topical formulations investigating hair growth potential and safety in healthy male volunteers for androgenetic alopecia has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• FOL-005

Snippet

Sponsor: Follicum AB | Conditions: Androgenetic Alopecia | Phase 2 | Status: COMPLETED